Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers
Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers
Active, not recruiting · NCT00223171 · Registry updated 2025-01-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 3 | 2025-01-27 | NCT00223171 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Université de Sherbrooke | 84 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre de Recherche Clinique du CHUS | Sherbrooke | Canada | 2 |